
1001 - 5000 employees
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
Biotechnology • Pharmaceuticals • Healthcare Insurance
Sumitomo Pharma America, Inc. is dedicated to improving the health and well-being of people around the world by driving innovative treatments, science, and technology. The company focuses on addressing patient needs in critical areas such as psychiatry & neurology, oncology, urology, women's health, rare diseases, and cell & gene therapy. As a subsidiary of Sumitomo Pharma Co. , Ltd. , SMPA embodies the promise of combining technology and life-sciences expertise to improve patient outcomes. With a diverse pipeline of preclinical and clinical programs, SMPA is committed to delivering patient-first solutions through a technology-driven approach.
🔥 0 minutes ago
Improve your chances of getting an interview by checking your resume score before you apply.

1001 - 5000 employees
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
Biotechnology • Pharmaceuticals • Healthcare Insurance
Sumitomo Pharma America, Inc. is dedicated to improving the health and well-being of people around the world by driving innovative treatments, science, and technology. The company focuses on addressing patient needs in critical areas such as psychiatry & neurology, oncology, urology, women's health, rare diseases, and cell & gene therapy. As a subsidiary of Sumitomo Pharma Co. , Ltd. , SMPA embodies the promise of combining technology and life-sciences expertise to improve patient outcomes. With a diverse pipeline of preclinical and clinical programs, SMPA is committed to delivering patient-first solutions through a technology-driven approach.
• Lead OUS Market Access Strategy and plan and an overall commercialization Execution • Lead development and execution of OUS market access, pricing, and reimbursement strategies across priority OUS markets, aligned with centrally defined global strategy • Translate overall global strategic objectives into actionable OUS launch plan including the market access workstreams, milestones, and deliverables aligned with global timelines • Own and drive day-to-day execution of OUS market access priorities across assets, ensuring alignment to central strategy, timelines, and long-range plans • Drive OUS launch readiness activities related to access pathways, reimbursement planning, and pricing implementation • Identify market-specific access risks, reimbursement barriers, policy constraints, and operational dependencies that may impact OUS launch readiness or uptake • Contribute to long-range planning for international access, including launch sequencing assumptions, affordability considerations, and stakeholder engagement priorities • Provide structured ex-US market insights to inform global access strategy, evidence planning, and value narrative development • Lead HTA planning and execution across priority markets, including EU JCA and relevant country-level reimbursement pathways • Develop country-level pricing and reimbursement recommendations aligned with centrally defined pricing guardrails • Support pricing and reimbursement negotiations in partnership with regional stakeholders, affiliates, and external partners as applicable • Monitor international pricing, reimbursement, and policy developments—including reference pricing and analogous cross-market risks—and recommend mitigation strategies • Represent ex-US access perspectives in cross-functional planning and governance forums, escalating key tradeoffs and recommendations as appropriate • Accountable for OUS access outcomes, including HTA success, reimbursement readiness, pricing alignment, and time to market access
• Bachelor’s degree required; advanced degree preferred (e.g., MBA, MPH, PharmD, PhD, MS, or equivalent) • 10+ years of progressive business experience in the healthcare, pharma or biotech industry, inclusive of global market access, pricing & reimbursement, value strategy, HEOR interface, or global commercial strategy; experience in cell, gene, and regenerative medicines a plus • Experience with EU markets and country-level HTAs, pricing and reimbursement; JCA experience preferred • Strong understanding of payer, reimbursement, HTA, and access dynamics in OUS settings • Ability to synthesize clinical, economic, operational, and policy information into clear strategic recommendations • Excellent communication, executive presence, and stakeholder management skills • Experience in rare disease, specialty therapeutics, biologics, cell therapy, gene therapy, tissue-based therapies, or other advanced modalities highly preferred • Experience partnering with regional teams, affiliates, distributors, or external commercialization partners • Must be comfortable spending 30% of time traveling; some overnight travel required
• merit-based salary increases • short incentive plan participation • eligibility for our 401(k) plan • medical, dental, vision, life and disability insurances • flexible paid time off • 11 paid holidays plus additional time off for a shut-down period during the last week of December • 80 hours of paid sick time upon hire and each year thereafter
Apply Now🔥 6 minutes ago
Director leading outcomes and product direction for a rapidly growing EdTech company. Overseeing a cross-functional team dedicated to learner success and AI adoption.
🔥 9 minutes ago
Director handling Life New Business and Underwriting solutions at LexisNexis Risk Solutions. Leading product innovation and strategic market initiatives with B2B data analytics.
🔥 13 minutes ago
Regional Director leading Access & Reimbursement teams for Novartis Cardiovascular across the Mountain Central region. Responsible for managing a diverse set of field access professionals focused on patient access.
🔥 15 minutes ago
Director, Consult Partner at Kyndryl leading consulting engagements for public sector clients. Driving profitable growth and managing complex client relationships in SLED sectors.
🔥 27 minutes ago
Associate Director for Strategic Accounts at Evolent, connecting healthcare pieces for improved outcomes. Managing client relationships, driving growth, and enhancing client satisfaction.